Melanotan 2 Reddit: Tanning Peptide — Real Experiences, Risks & Protocols

Overview

We analyzed hundreds of posts across r/Peptides, r/MT2, and r/malegrooming to find what real users say about Melanotan 2. MT2 is a synthetic analogue of alpha-melanocyte-stimulating hormone (α-MSH) that dramatically accelerates skin tanning by stimulating melanin production. It has been used off-label for tanning, sexual dysfunction, and weight loss for decades, accumulating a passionate — and polarized — community. The discussions are frank about both results and risks, making Reddit one of the most information-dense resources available for prospective users. This article compiles those experiences alongside the available clinical literature.

Community Consensus: What Reddit Agrees On

After analyzing hundreds of MT2 threads, the community has reached remarkably consistent conclusions. Injection is superior to nasal spray — this is practically dogma in r/MT2. Nasal spray versions are viewed as largely ineffective or requiring 3–4x the dose to match injectable results. The tanning effect is real, reliable, and noticeable: users with pale skin regularly post before/after photos showing dramatic color change in 2–4 weeks. The sexual side effects — particularly spontaneous erections in men — are treated almost as a given rather than a warning. Most users develop a tolerance-based system: high loading doses initially, then low maintenance to maintain color. Nausea on the first few injections is accepted as a rite of passage. The most contested topic is mole darkening and cancer risk, which generates ongoing debate without clear resolution.

Real User Experiences: Tanning Timeline

The tanning timeline reported by Reddit users follows a fairly predictable pattern regardless of starting skin tone. Fitzpatrick skin types I–II (very fair/red-haired) see the most dramatic changes but also require the most doses. Types III–IV tan faster and with lower total doses. The general community-reported timeline is as follows: initial color change appears around day 5–10 at loading doses; a noticeable tan develops by week 2–3; a deep, even tan is typically achieved by week 4–6. Many users specifically report that MT2 produces a natural-looking tan — more even than UV-induced tanning — which is attributed to its systemic mechanism affecting all melanocytes rather than just UV-exposed areas. Freckling and increased pigmentation in existing spots are also commonly noted.

• Days 1–7: Minimal visible change, mostly "priming" melanocytes
• Days 7–14: First noticeable color on face, chest, arms
• Weeks 2–4: Accelerating tan with UV exposure (10–20 min/day)
• Weeks 4–6: Deep, even tan achieved in most skin types
• Maintenance: 0.25–0.5 mg weekly or biweekly to hold color

Sexual Side Effects: The Elephant in the Room

No discussion of Melanotan 2 is complete without addressing its potent sexual effects. MT2 activates MC4R receptors in the central nervous system, which are involved in sexual arousal pathways. In men, this translates to spontaneous, often unwanted erections — sometimes within 1–2 hours of dosing. Women report significantly increased libido and arousal. These effects are so consistent that PT-141 (bremelanotide), a metabolite of MT2, was developed specifically as a sexual dysfunction treatment and is now FDA-approved. Reddit users have a range of reactions: some use MT2 specifically for this effect, others view it as a disruptive side effect to be managed by timing doses appropriately (evening injections being the most common workaround). The sexual effects tend to attenuate with prolonged use but rarely disappear entirely.

• Spontaneous erections: Reported by 70–80%+ of male users at loading doses
• Increased libido: Reported across all sexes
• Onset: 1–4 hours post-injection
• Management: Evening dosing, dose reduction, or accepting as a benefit
• PT-141: FDA-approved version specifically for sexual dysfunction (bremelanotide)

Nausea and First-Dose Side Effects

Nausea is the most commonly reported initial side effect, affecting the majority of users on their first 3–7 injections. The r/MT2 community has developed several harm-reduction strategies that have become standard practice. Antihistamines (particularly cetirizine/loratadine) taken 30 minutes before injection significantly reduce nausea and flushing for many users. Starting with a very low dose — 0.1–0.25 mg for the first injection — is strongly recommended. Injecting in the evening helps users sleep through the worst side effects. Face flushing, yawning, and lethargy in the first hour post-injection are also common at higher doses. These first-dose effects consistently diminish with subsequent injections as the body adapts, typically resolving by week 2.

Mole Darkening and Cancer Risk: The Controversial Question

The most contentious topic in MT2 communities is mole darkening and whether it signals cancer risk. MT2 stimulates all melanocytes — including those in existing moles — leading to visible darkening of existing nevi in many users. The dermatological community's concern is that melanocyte stimulation could promote the growth of existing atypical nevi or theoretically increase melanoma risk. Reddit discussions reflect genuine disagreement. Long-term users point to the absence of documented MT2-linked melanoma cases in the literature. Critics cite the theoretical mechanism and several case reports of rapidly changing moles during MT2 use. The current scientific consensus is that there is no confirmed causal link between MT2 and melanoma, but the mechanism provides theoretical grounds for concern. The community's harm-reduction recommendation is consistent: baseline dermatology assessment before starting, avoiding MT2 with any history of atypical moles or personal/family melanoma history, and annual skin checks during use.

Clinical Evidence: What the Research Shows

MT2 was originally developed at the University of Arizona in the 1980s as a potential therapeutic for photoprotection and sexual dysfunction. Clinical trials have been limited, but several findings are relevant. A Phase II trial demonstrated significant increases in melanin density and cosmetic tanning with minimal systemic exposure. The melanocortin system MT2 targets has well-established roles in pigmentation (MC1R), sexual function (MC4R), and energy homeostasis (MC3R/MC4R). The PT-141 (bremelanotide) FDA approval in 2019 provides indirect validation that the MC4R mechanism is pharmacologically active and clinically meaningful in humans. Animal studies have raised questions about melanoma promotion in susceptible animal models, but direct extrapolation to humans remains unclear. No large-scale human cancer outcome data exist for MT2 specifically.

Nasal Spray vs Injection: What the Community Recommends

r/MT2 is remarkably unified on this point: injection is the gold standard. Nasal spray versions circulate widely in grey markets, often marketed as a "more convenient" alternative, but the Reddit consensus is largely negative. Bioavailability of nasal MT2 is estimated to be significantly lower than subcutaneous injection — some users report needing 4–5x the stated dose to get comparable results. Many nasal spray products in the grey market are of questionable purity and concentration. Users who switched from spray to injection consistently report dramatically better results. The main appeal of nasal spray — avoiding needles — is acknowledged, but experienced users consider it a significantly compromised approach.

• Injection (SC): Gold standard per community consensus
• Nasal spray: Lower bioavailability, variable quality, less predictable dosing
• Needle gauge: 29–31G insulin syringes are standard
• Injection site: Abdomen or thigh, rotated to prevent lipodystrophy
• Reconstitution: Bacteriostatic water, 1–2 mL per 10 mg vial

Dosing Protocols: Loading vs Maintenance

The MT2 community has converged on a two-phase dosing protocol that mirrors the approach used in the original research studies. Loading phase: daily injections of 0.5–1 mg per day combined with UV exposure (10–20 minutes of natural sunlight or tanning bed). This phase typically lasts 2–6 weeks depending on baseline skin tone and desired color depth. Maintenance phase: once the desired tan is achieved, most users drop to 0.25–0.5 mg once or twice per week, combined with continued UV exposure, to maintain color. Some users in high-sun climates maintain with once-monthly dosing plus natural sun exposure. The most experienced community members emphasize that UV exposure is essential — MT2 primes melanocytes but UV light is still needed to trigger melanin synthesis and deposition. Using MT2 without any UV exposure produces markedly inferior results.

• Loading: 0.5–1 mg/day × 2–6 weeks + 10–20 min UV/day
• Maintenance: 0.25–0.5 mg 1–2×/week + continued UV exposure
• Starting dose: 0.1–0.25 mg to assess sensitivity
• Maximum: Most users cap at 1 mg/day; higher doses increase side effects without proportional benefit
• Antihistamine pretreatment: Popular strategy for reducing nausea

Legal Status and Controversy

Melanotan 2's legal status is genuinely complex and varies significantly by country. In the US, MT2 is not FDA-approved and is sold as a "research chemical" — legal to possess but illegal to sell for human consumption. In the UK, MT2 is listed as a prescription-only medicine under the Medicines Act, making unlicensed sale illegal, though personal possession is not a criminal offense. In Australia, MT2 is classified as a Schedule 4 substance. Across Europe, legal status varies by country. The grey market for MT2 is extensive, and quality control is a significant concern — users frequently discuss third-party testing services and how to identify underdosed or contaminated products. Reddit threads regularly include discussions of sourcing, which is a reminder that this is not a regulated product with quality guarantees.

Verdict: Who Should (and Shouldn't) Use MT2

The Reddit community's collective experience suggests MT2 is highly effective for its intended off-label purpose — producing a rapid, even tan — but comes with a distinctive side effect profile that not everyone finds acceptable. The sexual side effects, while sought by some users, are disruptive for others. The mole darkening question remains unresolved and represents a genuine consideration for anyone with risk factors. The community's harm-reduction approach is pragmatic: start low, pre-dose with antihistamine, inject in the evening, combine with UV exposure, and get a baseline dermatology assessment. MT2 is clearly not for people with a history of melanoma, atypical moles, or significant mole burden without expert medical oversight.

References

1. Melanotan II: An Overview of a Tanning Agent and Sexual Function Peptide (2004) — PubMed
2. Bremelanotide: An Overview of the Melanocortin System in Sexual Dysfunction (2017) — PubMed
3. Melanocyte-Stimulating Hormones and Melanocortin Receptors: Mediators of UV Responses and Skin Pigmentation (2014) — PubMed
4. Spontaneous Darkening of Melanocytic Nevi Associated with Use of Melanotan II (2009) — PubMed
5. The MC4R Melanocortin Receptor and Sexual Function in Humans (2011) — PubMed